Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside

Identifieur interne : 001306 ( Main/Exploration ); précédent : 001305; suivant : 001307

Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside

Auteurs : S. H. Yim [États-Unis] ; R. G. Farrer [États-Unis] ; J. A. Hammer [États-Unis] ; E. Yavin [États-Unis, Israël] ; R. H. Quarles [États-Unis]

Source :

RBID : ISTEX:6B3ABB3109BDC59825B558C49E03926FD5CEBAD8

English descriptors

Abstract

Cultures consisting primarily of O‐2A progenitor cells and immature oligodendrocytes with a few microglia and astrocytes were obtained by shaking primary cultures from neonatal rat brain after 12‐‐14 days in vitro. Addition of 50 μg/ml exogenous Neu‐NAcα2‐3Galβ1‐1′ ceramide (GM3 ganglioside) to the cultures resulted in an increase in the number and thickness of cell processes that stained intensely for sulfatide and galactocerebroside (galC) in comparison to control cultures without added GM3. The treated cultures also contained fewer astrocytes than control cultures as revealed by immunostaining for glial fibrillary acidic protein (GFAP). Cells that immunostained for both GFAP and sulfatide/galC were very rare in control cultures but were frequently seen in the GM3‐treated cultures, suggesting that these may represent cells changing their direction of differentiation away from type II astrocytes toward oligodendrocytes under the influence of GM3. These effects on the developing rat oligodendrocytes were specific for GM3 ganglioside and were not produced by adding GM1, GM2, GD3, or GD1a to the cultures. Lactosyl ceramide and neuraminyl lactose were also ineffective. When control cultures were initially plated on polylysine and incubated with [14C]galactose, GD3 was the principal labeled ganglioside. However, as the control cells differentiated over time in culture without the addition of exogenous GM3 and produced increasing amounts of myelin‐related components, the incorporation of [14C]galactose into endogenous GM3 increased to become the predominant labeled ganglioside by 6 days after plating. Metabolic labeling of the GM3‐treated oligodendrocytes with [14C]galactose revealed increased incorporation into galC and sulfatide in comparison to control cultures, but a decreased labeling of endogenous GM3. Similarly, incorporation of an amino acid precursor into the myelin‐associated glycoprotein (MAG) was increased by GM3 treatment, but incorporation into myelin basic protein (MBP) was not affected. Although the overall effect of added GM3 was to decrease the phosphorylation of most proteins in the oligodendrocytes, including MBP, GM3 enhanced the phosphorylation of MAG. These findings indicate that GM3 ganglioside has an important role in the differentiation of cells of the O‐2A lineage toward myelin production, since differentiation is associated with increased metabolic labeling of endogenous GM3 in control cultures and is enhanced by the addition of exogenous GM3. © 1994 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.

Url:
DOI: 10.1002/jnr.490380305


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside</title>
<author>
<name sortKey="Yim, S H" sort="Yim, S H" uniqKey="Yim S" first="S. H." last="Yim">S. H. Yim</name>
</author>
<author>
<name sortKey="Farrer, R G" sort="Farrer, R G" uniqKey="Farrer R" first="R. G." last="Farrer">R. G. Farrer</name>
</author>
<author>
<name sortKey="Hammer, J A" sort="Hammer, J A" uniqKey="Hammer J" first="J. A." last="Hammer">J. A. Hammer</name>
</author>
<author>
<name sortKey="Yavin, E" sort="Yavin, E" uniqKey="Yavin E" first="E." last="Yavin">E. Yavin</name>
</author>
<author>
<name sortKey="Quarles, R H" sort="Quarles, R H" uniqKey="Quarles R" first="R. H." last="Quarles">R. H. Quarles</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6B3ABB3109BDC59825B558C49E03926FD5CEBAD8</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/jnr.490380305</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-LFCRNF2T-K/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000763</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000763</idno>
<idno type="wicri:Area/Istex/Curation">000743</idno>
<idno type="wicri:Area/Istex/Checkpoint">000475</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000475</idno>
<idno type="wicri:doubleKey">0360-4012:1994:Yim S:differentiation:of:oligodendrocytes</idno>
<idno type="wicri:Area/Main/Merge">001322</idno>
<idno type="wicri:Area/Main/Curation">001306</idno>
<idno type="wicri:Area/Main/Exploration">001306</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside</title>
<author>
<name sortKey="Yim, S H" sort="Yim, S H" uniqKey="Yim S" first="S. H." last="Yim">S. H. Yim</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Correspondence address: Building 49, Room 2A28, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Farrer, R G" sort="Farrer, R G" uniqKey="Farrer R" first="R. G." last="Farrer">R. G. Farrer</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hammer, J A" sort="Hammer, J A" uniqKey="Hammer J" first="J. A." last="Hammer">J. A. Hammer</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Yavin, E" sort="Yavin, E" uniqKey="Yavin E" first="E." last="Yavin">E. Yavin</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Current Address: Department of Neurobiology, Weizmann Institute of Science, Rehovot</wicri:regionArea>
<wicri:noRegion>Rehovot</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Quarles, R H" sort="Quarles, R H" uniqKey="Quarles R" first="R. H." last="Quarles">R. H. Quarles</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Laboratory of Molecular and Cellular Neurobiology, NINDS, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Neuroscience Research</title>
<title level="j" type="alt">JOURNAL OF NEUROSCIENCE RESEARCH</title>
<idno type="ISSN">0360-4012</idno>
<idno type="eISSN">1097-4547</idno>
<imprint>
<biblScope unit="vol">38</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="268">268</biblScope>
<biblScope unit="page" to="281">281</biblScope>
<biblScope unit="page-count">14</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1994-06-15">1994-06-15</date>
</imprint>
<idno type="ISSN">0360-4012</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0360-4012</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Astrocyte</term>
<term>Biol</term>
<term>Cell biol</term>
<term>Cell bodies</term>
<term>Cell growth</term>
<term>Cellular protein</term>
<term>Ceramide</term>
<term>Control cells</term>
<term>Control cultures</term>
<term>Culture media</term>
<term>Differentiation</term>
<term>Dmem</term>
<term>Endogenous</term>
<term>Exogenous</term>
<term>Exogenous gangliosides</term>
<term>Fine processes</term>
<term>Galc</term>
<term>Ganglioside</term>
<term>Gangliosides</term>
<term>Gfap</term>
<term>Glial</term>
<term>Glycolipids</term>
<term>Glycoprotein</term>
<term>Gm3treated cells</term>
<term>Growth factor</term>
<term>Immature oligodendrocytes</term>
<term>Immunostaining</term>
<term>Important role</term>
<term>Incorporation</term>
<term>Kinase</term>
<term>Ledeen</term>
<term>Lineage</term>
<term>Lipid</term>
<term>Little effect</term>
<term>Myelin</term>
<term>Myelin proteins</term>
<term>Neurite outgrowth</term>
<term>Neurochem</term>
<term>Neurosci</term>
<term>Oligodendrocyte</term>
<term>Oligodendrocyte development</term>
<term>Oligodendrocyte differentiation</term>
<term>Pgiml</term>
<term>Phosphorylation</term>
<term>Plating</term>
<term>Polylysine</term>
<term>Precursor</term>
<term>Primary cultures</term>
<term>Proc natl acad</term>
<term>Process formation</term>
<term>Progenitor</term>
<term>Protein kinase</term>
<term>Quarles</term>
<term>Radioactive galactose</term>
<term>Receptor</term>
<term>Specific activity</term>
<term>Sphingoglycolipids</term>
<term>Sulfatide</term>
<term>Thick processes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cultures consisting primarily of O‐2A progenitor cells and immature oligodendrocytes with a few microglia and astrocytes were obtained by shaking primary cultures from neonatal rat brain after 12‐‐14 days in vitro. Addition of 50 μg/ml exogenous Neu‐NAcα2‐3Galβ1‐1′ ceramide (GM3 ganglioside) to the cultures resulted in an increase in the number and thickness of cell processes that stained intensely for sulfatide and galactocerebroside (galC) in comparison to control cultures without added GM3. The treated cultures also contained fewer astrocytes than control cultures as revealed by immunostaining for glial fibrillary acidic protein (GFAP). Cells that immunostained for both GFAP and sulfatide/galC were very rare in control cultures but were frequently seen in the GM3‐treated cultures, suggesting that these may represent cells changing their direction of differentiation away from type II astrocytes toward oligodendrocytes under the influence of GM3. These effects on the developing rat oligodendrocytes were specific for GM3 ganglioside and were not produced by adding GM1, GM2, GD3, or GD1a to the cultures. Lactosyl ceramide and neuraminyl lactose were also ineffective. When control cultures were initially plated on polylysine and incubated with [14C]galactose, GD3 was the principal labeled ganglioside. However, as the control cells differentiated over time in culture without the addition of exogenous GM3 and produced increasing amounts of myelin‐related components, the incorporation of [14C]galactose into endogenous GM3 increased to become the predominant labeled ganglioside by 6 days after plating. Metabolic labeling of the GM3‐treated oligodendrocytes with [14C]galactose revealed increased incorporation into galC and sulfatide in comparison to control cultures, but a decreased labeling of endogenous GM3. Similarly, incorporation of an amino acid precursor into the myelin‐associated glycoprotein (MAG) was increased by GM3 treatment, but incorporation into myelin basic protein (MBP) was not affected. Although the overall effect of added GM3 was to decrease the phosphorylation of most proteins in the oligodendrocytes, including MBP, GM3 enhanced the phosphorylation of MAG. These findings indicate that GM3 ganglioside has an important role in the differentiation of cells of the O‐2A lineage toward myelin production, since differentiation is associated with increased metabolic labeling of endogenous GM3 in control cultures and is enhanced by the addition of exogenous GM3. © 1994 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Israël</li>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Yim, S H" sort="Yim, S H" uniqKey="Yim S" first="S. H." last="Yim">S. H. Yim</name>
</region>
<name sortKey="Farrer, R G" sort="Farrer, R G" uniqKey="Farrer R" first="R. G." last="Farrer">R. G. Farrer</name>
<name sortKey="Hammer, J A" sort="Hammer, J A" uniqKey="Hammer J" first="J. A." last="Hammer">J. A. Hammer</name>
<name sortKey="Quarles, R H" sort="Quarles, R H" uniqKey="Quarles R" first="R. H." last="Quarles">R. H. Quarles</name>
<name sortKey="Yavin, E" sort="Yavin, E" uniqKey="Yavin E" first="E." last="Yavin">E. Yavin</name>
<name sortKey="Yim, S H" sort="Yim, S H" uniqKey="Yim S" first="S. H." last="Yim">S. H. Yim</name>
</country>
<country name="Israël">
<noRegion>
<name sortKey="Yavin, E" sort="Yavin, E" uniqKey="Yavin E" first="E." last="Yavin">E. Yavin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001306 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001306 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6B3ABB3109BDC59825B558C49E03926FD5CEBAD8
   |texte=   Differentiation of oligodendrocytes cultured from developing rat brain is enhanced by exogenous GM3 ganglioside
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021